Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization | MicrobiomeTrials← Back to trialsNCT07512960
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-05-30Est. Completion: 2030-05-30
Enrollment target: 614 participants Other microbiome trials you might be interested in
CLTI Defined as Rutherford Category 4 or 5PAOD (Peripheral Arterial Obstructive Disease)
The aim of this clinical trial is to learn if the resorbable scaffold can be successfully implanted in below-the-knee ar…
Tashkent, UzbekistanEst. completion Dec 1, 2026
Peripheral Arterial DiseaseChronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (u…
Chandler, United StatesEst. completion Jun 1, 2027